bpc 157 human clinical trials evidence safety BPC-157: Miracle Healing Peptide or Hidden Danger? bpc-157 human clinical trials evidence
Description
Always consult a licensed healthcare professional regarding medical decision.
Three pilot studies
Thereafter, 100 mcg should be injected once a month for life
They are organized, efficient and responsive professionals and good humans to their clients
Protocols commonly use subcutaneous injection in a loading-then-maintenance pattern over 46 week blocks, but there is no FDA-approved product or official dosing
As time passed, case reports, case series and casecontrol studies from all over the world were published, revealing new post-vaccination disease occurrence or disease flare up
